Evaluation of the permeation of antineoplastic agents through medical gloves of varying materials and thickness and with varying surface treatments

Table 1 Antineoplastic agents used in this study

Antineoplastic agents	Brand name	Concentration [mg/mL]	MW^a	logP^b
Etoposide	Lastet® Inj. 100 mg/5 mL (Nippon Kayaku Co., Ltd)	20	588.6	0.6 [13]
Cyclophosphamide monohydrate	Endoxan® 100 mg (Shionogi & Co., Ltd)	20	261.1^c	0.6 [13]
Doxorubicin hydrochloride	ADRIACIN® Injection 10 (Kyowa Hakko Kirin Co., Ltd)	10	543.5^d	1.4 [14]
Paclitaxel	TAXOL® INJECTION 30 mg (Bristol-Myers Squibb)	6	853.9	3.7 [15]
Fluorouracil	5-FU Injection 250 Kyowa® (Kyowa Hakko Kirin Co., Ltd.)	50	130.8	−1.0 [16]

ISSN: 2055-0294